ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 49 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | -93.5% | 4,000 | -81.9% | 0.00% | – |
| Q2 2021 | $31,000 | -32.6% | 22,058 | -17.0% | 0.00% | – |
| Q1 2021 | $46,000 | -55.3% | 26,573 | -67.7% | 0.00% | – |
| Q4 2020 | $103,000 | -3.7% | 82,258 | +9.2% | 0.00% | – |
| Q3 2020 | $107,000 | -2.7% | 75,300 | -17.4% | 0.00% | – |
| Q2 2020 | $110,000 | -3.5% | 91,170 | -5.5% | 0.00% | – |
| Q1 2020 | $114,000 | -25.0% | 96,514 | +33.9% | 0.00% | – |
| Q4 2019 | $152,000 | -33.0% | 72,062 | -30.1% | 0.00% | – |
| Q3 2019 | $227,000 | -3.0% | 103,134 | +11.6% | 0.00% | – |
| Q2 2019 | $234,000 | -16.4% | 92,441 | +14.6% | 0.00% | – |
| Q1 2019 | $280,000 | +87.9% | 80,630 | +25.5% | 0.00% | – |
| Q4 2018 | $149,000 | -20.7% | 64,270 | +31.7% | 0.00% | – |
| Q3 2018 | $188,000 | +21.3% | 48,800 | +6.3% | 0.00% | – |
| Q2 2018 | $155,000 | +64.9% | 45,900 | +2.3% | 0.00% | – |
| Q1 2018 | $94,000 | +51.6% | 44,865 | +47.6% | 0.00% | – |
| Q4 2017 | $62,000 | -58.1% | 30,390 | -6.0% | 0.00% | – |
| Q3 2017 | $148,000 | +604.8% | 32,318 | +217.4% | 0.00% | – |
| Q2 2017 | $21,000 | -70.0% | 10,182 | -53.8% | 0.00% | – |
| Q1 2017 | $70,000 | +125.8% | 22,026 | +89.4% | 0.00% | – |
| Q4 2016 | $31,000 | +675.0% | 11,629 | +933.7% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 1,125 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 1,125 | +40.6% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | +50.0% | 800 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -89.5% | 800 | -81.8% | 0.00% | – |
| Q2 2015 | $19,000 | -51.3% | 4,400 | -56.2% | 0.00% | – |
| Q1 2015 | $39,000 | -38.1% | 10,047 | +6.9% | 0.00% | – |
| Q4 2014 | $63,000 | -11.3% | 9,400 | -27.1% | 0.00% | – |
| Q3 2014 | $71,000 | +26.8% | 12,900 | +134.5% | 0.00% | – |
| Q2 2014 | $56,000 | +300.0% | 5,500 | +358.3% | 0.00% | – |
| Q1 2014 | $14,000 | +100.0% | 1,200 | +87.8% | 0.00% | – |
| Q3 2013 | $7,000 | – | 639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |